• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Testosterone Replacement Therapy and Prostate Cancer Incidence.睾酮替代疗法与前列腺癌发病率
World J Mens Health. 2015 Dec;33(3):125-9. doi: 10.5534/wjmh.2015.33.3.125. Epub 2015 Dec 23.
2
Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends.前列腺癌诊断后的睾酮替代治疗:结局和应用趋势。
J Sex Med. 2014 Apr;11(4):1063-1070. doi: 10.1111/jsm.12429. Epub 2014 Jan 21.
3
Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register.睾酮对高级别前列腺癌有保护作用吗?553例接受前列腺活检患者的前列腺癌发病率及严重程度:一项前瞻性数据登记研究。
Aging Male. 2017 Jun;20(2):125-133. doi: 10.1080/13685538.2017.1298584. Epub 2017 Mar 10.
4
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.睾酮治疗与前列腺癌风险增加或下尿路症状恶化无关:男性性腺功能减退登记处的前列腺健康结果
BJU Int. 2017 Feb;119(2):216-224. doi: 10.1111/bju.13578. Epub 2016 Aug 14.
5
Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries.接受睾酮治疗的性腺功能减退症男性的前列腺癌发病率:3 个登记处中位随访 5 年的观察结果。
J Urol. 2015 Jan;193(1):80-6. doi: 10.1016/j.juro.2014.06.071. Epub 2014 Jun 26.
6
Effects of androgen deficiency and replacement on prostate zonal volumes.雄激素缺乏及替代对前列腺各区体积的影响。
Clin Endocrinol (Oxf). 2001 Apr;54(4):437-45. doi: 10.1046/j.1365-2265.2001.01240.x.
7
Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.接受睾酮替代疗法的性腺功能减退男性的前列腺特异性抗原变化与前列腺癌
BJU Int. 2009 May;103(9):1179-83. doi: 10.1111/j.1464-410X.2008.08240.x. Epub 2008 Dec 23.
8
Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer.改变前列腺癌睾酮替代疗法的模式
World J Mens Health. 2018 May;36(2):103-109. doi: 10.5534/wjmh.170007. Epub 2018 Mar 22.
9
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy.前列腺癌根治术后患者的睾酮替代治疗。
J Urol. 2013 Aug;190(2):639-44. doi: 10.1016/j.juro.2013.02.002. Epub 2013 Feb 8.
10
Late-onset hypogonadism: Prostate safety.迟发性性腺功能减退症:前列腺安全性。
Andrology. 2020 Nov;8(6):1606-1613. doi: 10.1111/andr.12772. Epub 2020 Feb 28.

引用本文的文献

1
Effect of Elderberry ( L.) Extract Intake on Normalizing Testosterone Concentration in Testosterone Deficiency Syndrome Rat Model Through Regulation of 17β-HSD, 5α-Reductase, and CYP19A1 Expression.接骨木提取物摄入对睾酮缺乏综合征大鼠模型中睾酮浓度正常化的影响:通过调节17β-羟类固醇脱氢酶、5α-还原酶和CYP19A1的表达
Nutrients. 2024 Nov 30;16(23):4169. doi: 10.3390/nu16234169.
2
Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size.长期睾酮治疗(TTh)可改善性腺功能低下男性的排尿功能,与前列腺体积无关。
Int Urol Nephrol. 2023 Jul;55(7):1649-1658. doi: 10.1007/s11255-023-03602-4. Epub 2023 May 6.
3
An Individualized Approach to Managing Testosterone Therapy in the Primary Care Setting.基层医疗环境中睾酮治疗的个体化管理方法
Int J Gen Med. 2022 Oct 7;15:7719-7733. doi: 10.2147/IJGM.S364189. eCollection 2022.
4
Burden of Male Hypogonadism and Major Comorbidities, and the Clinical, Economic, and Humanistic Benefits of Testosterone Therapy: A Narrative Review.男性性腺功能减退及其主要合并症的负担,以及睾酮治疗的临床、经济和人文益处:一项叙述性综述
Clinicoecon Outcomes Res. 2021 Jan 12;13:31-38. doi: 10.2147/CEOR.S285434. eCollection 2021.
5
Impact and Outcomes of Pretreatment Total Serum Testosterone on Localized Prostate Cancer Patients.治疗前血清总睾酮水平对局限性前列腺癌患者的影响及预后
Prostate Cancer. 2020 Jan 20;2020:8357452. doi: 10.1155/2020/8357452. eCollection 2020.
6
A Patient (46XX) With Congenital Adrenal Hyperplasia and Prostate Cancer: A Case Report.一名患有先天性肾上腺增生和前列腺癌的患者(46XX):病例报告
J Endocr Soc. 2017 Aug 17;1(9):1213-1216. doi: 10.1210/js.2017-00281. eCollection 2017 Sep 1.
7
Variation in Practice Pattern of Male Hypogonadism: A Comparative Analysis of Primary Care, Urology, Endocrinology, and HIV Specialists.男性性腺功能减退实践模式的差异:初级保健、泌尿外科、内分泌科和艾滋病专科医生的比较分析。
Am J Mens Health. 2018 Mar;12(2):472-478. doi: 10.1177/1557988317743152. Epub 2017 Nov 28.
8
The prostate response to prolactin modulation in adult castrated rats subjected to testosterone replacement.成年去势大鼠在补充睾酮后,催乳素调节对前列腺的反应。
J Mol Histol. 2017 Dec;48(5-6):403-415. doi: 10.1007/s10735-017-9738-z. Epub 2017 Oct 7.
9
Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case-control study.吡格列酮暴露与前列腺癌风险评估:一项巢式病例对照研究。
BMJ Open Diabetes Res Care. 2016 Dec 12;4(1):e000303. doi: 10.1136/bmjdrc-2016-000303. eCollection 2016.

本文引用的文献

1
Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer.低、中、高危前列腺癌放疗后的睾酮治疗
J Urol. 2015 Nov;194(5):1271-6. doi: 10.1016/j.juro.2015.05.084. Epub 2015 May 27.
2
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
3
Testosterone therapy and cancer risk.睾酮治疗与癌症风险。
BJU Int. 2015 Feb;115(2):317-21. doi: 10.1111/bju.12756. Epub 2014 Oct 20.
4
Associations of pretreatment serum total testosterone measurements with pathology-detected Gleason score cancer.治疗前血清总睾酮测量值与病理检测的 Gleason 评分癌症之间的关联。
Urol Int. 2014;93(3):269-78. doi: 10.1159/000354621. Epub 2013 Dec 11.
5
Study of testosterone as a predictor of tumor aggressiveness in patients with prostate cancer.研究睾酮作为前列腺癌患者肿瘤侵袭性的预测因子。
Int Braz J Urol. 2013 Mar-Apr;39(2):173-81. doi: 10.1590/S1677-5538.IBJU.2013.02.04.
6
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy.前列腺癌根治术后患者的睾酮替代治疗。
J Urol. 2013 Aug;190(2):639-44. doi: 10.1016/j.juro.2013.02.002. Epub 2013 Feb 8.
7
Circulating sex steroids and prostate cancer: introducing the time-dependency theory.循环性激素与前列腺癌:引入时相关理论。
World J Urol. 2013 Apr;31(2):267-73. doi: 10.1007/s00345-012-1009-8. Epub 2013 Jan 3.
8
Testosterone replacement therapy in the setting of prostate cancer treated with radiation.前列腺癌经放射治疗后的睾酮替代疗法。
Int J Impot Res. 2013 Jan;25(1):24-8. doi: 10.1038/ijir.2012.29. Epub 2012 Sep 13.
9
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.前列腺癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459.
10
Is testosterone treatment good for the prostate? Study of safety during long-term treatment.睾酮治疗对前列腺有益吗?长期治疗期间的安全性研究。
J Sex Med. 2012 Aug;9(8):2138-49. doi: 10.1111/j.1743-6109.2012.02808.x. Epub 2012 Jun 6.

睾酮替代疗法与前列腺癌发病率

Testosterone Replacement Therapy and Prostate Cancer Incidence.

作者信息

Eisenberg Michael Louis

机构信息

Departments of Urology, Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

World J Mens Health. 2015 Dec;33(3):125-9. doi: 10.5534/wjmh.2015.33.3.125. Epub 2015 Dec 23.

DOI:10.5534/wjmh.2015.33.3.125
PMID:26770932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4709428/
Abstract

While early studies demonstrated a positive association between testosterone and prostate cancer, evidence on the nature of the relationship has evolved with time and newer data. Studies examining links between baseline testosterone levels as well as testosterone therapy and incident prostate cancer, reveal a more complex relationship. Moreover, investigators have reported their initial experiences with supplementing testosterone in men with a history of both treated and untreated prostate cancer.

摘要

虽然早期研究表明睾酮与前列腺癌之间存在正相关,但随着时间推移和新数据的出现,关于这种关系本质的证据已经有所发展。研究基线睾酮水平以及睾酮治疗与前列腺癌发病之间的联系,揭示了一种更为复杂的关系。此外,研究人员报告了他们在有治疗和未治疗前列腺癌病史的男性中补充睾酮的初步经验。